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Surgical Removal of Metastatic Renal Adenocarcinoma to the 
Midbrain Tectum: A Case Report 
Frank J. Tomecek, MD,* James I. Ausman, MD, PhD,* and Ghaus M. Malik, MD* 
A patient with adenocarcinoma of the kidney metastatic lo the quadrigeminal plate of the midbrain 
presented with acute obstructive hydrocephalus and early tonsillar herniation. Because the majority 
of these carcinomas are resistant to radiation therapy, only limited treatment choices were available. 
Initially, a ventriculoperitoneal shunt relieved the hydrocephalus and neurologic symptoms. After a 
short course of improvement, with decompressed ventricles demonstrated hy postoperative computed 
tomography, the patient developed additional neurologic signs, leading to the decision to excise the 
metastatic tumor. Convalescence was complicated but the patient survivedfor six months, succumbing 
to respiratory failure presumably caused by lung metastases. (Henry Ford Hosp Med J 1990;38:72-5) 
Excision of a solitary intracranial metastasis can prolong and improve the life of carefully selected patients (t-5). Over the 
past several years uncontrolled retrospective studies of the effec-
tiveness of surgical treatment for metastases have yielded con-
flicting results; some have shown benefit from surgery (3,6,7), 
whereas others have not (8-10). A recent randomized prospec-
tive trial conducted by F^tchell et al (5) showed that patients with 
cancer who undergo surgical resection plus radiotherapy for a 
single brain metastasis live longer, have fewer recunences in the 
brain, and have a better quality of life than similar patients 
treated with radiotherapy atone. Nevertheless, the decision to 
operate on a cerebral metastasis is controversial. Gushing (11) 
and Dandy (12) were among the first to express their pessimism 
conceming this form of therapy. A critical factor when compar-
ing surgical intervention to other forms of treatment is the oper-
ative morbidity and mortality. Black (1) reported that operative 
mortality ranged from 11% to 21% with additional operative 
complications in 24% of patients undergoing excision of a soli-
tary cerebral metastasis. Others reported lower mortality and 
morbidity (13). In our unpublished series of craniotomies in 168 
patients with metastatic carcinoma of the lung (performed be-
tween 1955 and 1986), the operative mortality was 6.7% and 
morbidity was 15.3%. Recent improvement both in stereotactic 
localization of tumors and in microsurgical technique has re-
sulted in even lower operative mortality and morbidity (2). 
An unresolved issue is the operative approach to a solitary 
brainstem metastasis. Many believe that such tumors are in-
operable because of their critical location and should be treated 
by radiation therapy alone (14-18). We are aware of only two pre-
vious reports describing the surgical treatment for midbrain me-
tastasis (19,20). We present a patient with renal adenocarcinoma 
metastatic to the midbrain. Because an in i t i a l ventricu-
loperitoneal (VP) shunt did not relieve the symptoms of acute 
obstmctive hydrocephalus, microsurgical excision of the tumor 
was performed utilizing a carbon dioxide laser. 
Case Report 
In 1985 a 62-year-old man presented with a two-month history of 
progressive diplopia, ataxic gait, generalized weakness, and som-
nolence. In 1983 he had undergone nephrectomy with lymph node dis-
section for adenocarcinoma of the kidney (hypernephroma). Subse-
quently he received chemotherapy which included progesterone. In 
April 1984, a rib resection for recurrent cancer was followed by che-
motherapy with a combination of vinblastine, adriamycin, and 
Cytoxan. He recovered and was well for one year. 
On this admission examination revealed diplopia on both right and 
left lateral gaze. There was no papilledema. Extraocular movements 
were intact except for mild nystagmus on lateral gaze. The pupils re-
acted equally to light and accommodation. Neurologic examination re-
vealed poor short-term memory, dysmetria on the right with falling to 
the right during tandem walking and performance of the Romberg test. 
Computed tomography (CT) of the brain demonstrated a 1.5 cm en-
hancing mass involving the quadrigeminal plate and associated with 
hydrocephalus (Figure). Four vessel cerebral angiography showed a 
highly vascular, round, circumscribed mass which stained irregularly 
and was located in the dorsal rostral aspect of the midbrain. The mass 
displaced the precentral cerebellar vein posteriorly and the anterior 
pontomesencephalic vein anteriorly indicating an intraaxial mass. In 
view of the history, metastatic hypernephroma was suspected, although 
a highly vascular primary lesion could not be excluded. Chest x-ray ex-
hibited mild chronic obstructive pulmonary disease (COPD). Bone 
scan suggested the pwssibility of a single metastatic lesion in the left 
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Figure—Contrast-enhanced CT (left) reveals 1.5 cm homogeneously enhancing mass in the midbrain tectum. Postoperative CT 
(right) shows excision ofthe lesion and hypodense areas in the midbrain tectum and medial cerebellar hemisphere. 
eighth rib, liver-spleen scan was negative, and CT of the chest showed 
interstitial changes consistent with mild COPD. Presence of an en-
larged lymph node in the mediastinum was questioned but no intra-
parenchymal metastases were evident. 
Dexamethasone therapy was instituted, but because the patient failed 
to improve he underwent placement of a VP shunt. The ventriculostomy 
was placed in the left frontal hom in case a future right-sided cra-
niotomy became necessary. Cerebrospinal fluid obtained at the time of 
surgery was negative for infection or abnormal cytology. 
Following placement of the VP shunt, the patient exhibited increased 
short-term memory and was less somnolent. He was discharged home 
on the sixth postoperative day receiving decreasing doses of dexa-
methasone. 
One month later he retumed because of recurrent diplopia, worsen-
ing of right-sided dysmetria, ataxia, and somnolence. Examination dis-
closed a mild right abducens nerve palsy, persistent diplopia, and dys-
metria oflhe right arm and leg. CT showed normal-sized ventricles with 
the VP shunt in place and an enlarged mass in the midbrain tectum ex-
tending to the superior medullary velum. Six weeks following VP shunt 
placement the tumor was excised. Preoperatively the patient received 
loading doses of dexamethasone and phenytoin, both of which were 
continued postoperatively. 
Operation 
With the patient in the three-quarters prone, operated side down posi-
tion, a right parietal-occipital craniotomy was performed (21). The pa-
tient received furosemide and mannitol, and 100 mL of cerebrospinal 
fluid was drained through the spinal drain providing a slack brain. The 
occipital lobe was retracted laterally with minimal pressure and the ten-
torium was exposed. Incision of the tentorium parallel to the straight 
sinus exposed the superior cerebellum and vermis. A branch ofthe su-
perior cerebellar artery was followed proximally leading to the cistem 
ofthe quadrigeminal plate. The area between the vein of Galen and the 
superior cerebellar artery contained a yellow amorphous mass. The tu-
mor appeared to arise from the superior medullary velum and from the 
inferior colliculus. Because it was highly vascular, the tumor was re-
moved piecemeal using bipolar electrocautery and a carbon dioxide 
laser thereby achieving adequate hemostasis. Although most of the tu-
mor was resected, distinguishing tumor from the surrounding tissue 
was very difficult along its margins. The histological diagnosis was 
consistent with metastatic renal adenocarcinoma of the clear cell type. 
Postoperative course 
After the operation the patient exhibited a mild left hemiparesis. Al-
though lethargic, he was easily aroused and followed commands appro-
priately. He required ventilatory support. Postoperative CT showed col-
lapse of the ventricular system with effacement of the subarachnoid 
cisterns indicating increased intracranial pressure. Therefore, the pa-
tient was treated with mannitol, dexamethasone, and hyperventilation. 
Ten days postoperatively, while still requiring mechanical ventilation, 
he developed tracheobronchitis caused by hemophilus influenza and re-
ceived a course of ampicillin. Five weeks postoperatively the patient 
was extubated and transferred from the intensive care unit (ICU). His 
prolonged stay in the ICU was primarily because of persistent increased 
tracheobronchial secretions and a continued need for ventilatory as-
sistance. A few days later the patient exhibited repetitive chewing 
movements of his mouth and tongue and had a poor gag reflex. These 
movements were thought to be facial myoclonus and clonazepam was 
added to the increased dose of phenytoin. His postoperative course was 
also complicated by a urinary tract infection and an allergic reaction, 
probably to phenytoin, which was replaced by trihexyphenidyl and car-
bamazepine. With therapy, the patient became able to communicate 
short sentences. He required assistance with feeding and ambulation 
because of persistent moderate dysmetria of the right hand and leg. He 
also displayed mild lefl hemiparesis. 
CT prior to discharge showed the following: a hypodense lesion 
along the right posterior midbrain probably represented the site of re-
section of the metastasis; an area of hypodensity in the right cerebellar 
hemisphere suggested an infarct; and a small curvilinear zone of en-
hancement of the lateral aspect of the surgical bed possibly represented 
postoperative enhancement, but residual tumor could not be excluded. 
The ventricles were small but not collapsed, and no mass effect was 
noted on the fourth ventricle. 
Planned postoperative radiation therapy, 3,000 rads to the whole 
brain followed by an additional 1,000 to 1,500 rads to the metastatic 
tumor, was refused by the patient. He was discharged to a rehabilitation 
center 
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During the next three months the patient slowly improved in ambula-
tion and speech but he developed a productive cough. A chest x-ray 
demonstrated lung masses, presumably metastases, and he died at 
home one month later from respiratory failure. 
Discussion 
Central nervous system (CNS) metastases occur in approx-
imately 15% to 20% of patients dying of cancer, and one-third of 
these are solitary (18,22). Solitary brainstem metastases, on the 
other hand, are rare. By 1983, Delaney and Martinez (23) stated 
that onty 40 cases had been adequately described and several of 
these had been documented only by radiographs, not biopsy or 
necropsy. The ratio of the number of cases of solitary CNS me-
tastasis to the number of solitary brainstem metastasis is 32:1, 
not significantly different from the ratio of weights of the in-
votved stmctures (18). Thus, the brainstem is probably no more 
or less susceptible to metastasis than the remainder of the CNS. 
When operating on the brainstem, the extent of the lesion 
must be precisely defined. Because it can distinguish infiltrating 
from welt circumscribed tumors, magnefic resonance imaging 
(MRI) may be the study of choice for posterior fossa disease 
(24,25). However, T2-weighted MRI images are less reliable 
than contrast-enhanced CT in differentiating edema from tumor 
mass (22). Contrast-enhanced CT images have been reported to 
conelate closely with autopsy findings of solitary brainstem me-
tastasis (17). Additional studies wUl be necessary before the 
same can be said about enhanced MRI. Perhaps the most accu-
rate way to differentiate tumor from sunounding edema is to as-
sess glucose utilization by the tissue using positron emission to-
mography (PET). Tumors exhibit high glucose utilization which 
can be contrasted from the tower glucose utilization of surround-
ing edematous tissue. Unlike MRI or CT, PET can also be used 
to differentiate recunent tumor from postradiotherapy necrosis 
(26,27). 
The neurosurgical approach to metastatic disease of the cen-
tral nervous system includes tumor excision, decompression 
and/or cerebrospinal fluid shunting, or stereotaxic biopsy and 
interstitial radiation therapy (28). Altematively, one may choose 
not to operate but to attempt palliation with radiation. The pro-
spective randomized study of Patchell et al (5) has shown the 
advantages of surgical treatment for singte metastasis to the 
brain. The indicafions for surgical treatment of single metastasis 
to the brainstem are not established. Tomita and Wetzel (17) as 
wett as Weiss and Richardson (18) advised against operation for 
brainstem metastasis because of the critical location of the 
tumor. 
To our knowledge, surgical excision of brainstem metastasis 
has been described only in two other cases. Hacker and Fox (19) 
were the first to report an attempt at surgical excision of a soli-
tary brainstem metastasis in 1980. Their indications for surgery 
were to establish a diagnosis and because of increasing mass ef-
fect and fourth ventricle shift. They agreed with the radiologic 
indications for exploration of brainstem neoplasms recom-
mended by Lassman (29); 1) marked hydrocephalus, 2) more 
than slight deviation of the fourth ventricle and aqueduct from 
the midline, and 3) a filling defect ofthe fourth ventricle. Tobler 
et al (20) first reported the complete excision of metastatic ade-
nocarcinoma of the lung to the midbrain. Their decision to oper-
ate was based upon failure of radiation to palliate the patient's 
symptoms, the increasing size of the mass, lack of apparent ac-
tive primary disease, the patient's generally favorable medical 
condition, and the long latent period which preceded the ap-
pearance of cerebral metastasis (1,18), With advanced micro-
surgery and the use of laser vaporization, Tobler et at (20) could 
decompress space occupying metastasis to the brainstem and 
obtain excellent postoperative results, Kelly et at (2) described 
stereotactic localization and successful excision of an alveolar 
cell carcinoma of the lung metastatic to the right middle cere-
bellar peduncle There is yet no report of stereotactic biopsy and 
interstitial radiation, but if the radiation could be confined to the 
tumor, this approach might be very successful, 
In our case the patient presented with hydrocephalus, right 
cerebellar dysfunction probably due to involvement of the right 
superior cerebellar peduncle, a mass effect on the brainstem, 
and early tonsillar hemiation. He had a well-differentiated car-
cinoma of the kidney. Metastases of these neoplasms often ex-
hibit indolent behavior after ablation of the source (30,31). Re-
nal cell carcinomas are relatively resistant to radiation therapy 
(1,28). Although surgical excision was considered, the lower 
risk shunting procedure was chosen initially to obtain symp-
tomatic relief from obstmctive hydrocephalus. However, when 
the symptoms worsened one month postoperatively, we pro-
ceeded to excise the tumor. Survival with metastases unprece-
dented in other tumors has been documented in hypemephroma 
(32) and even cure after removal of a cerebral hemisphere metas-
tasis has been recorded (33). 
These unique characteristics of metastatic hypemephroma in-
fluenced our decision toward surgery. Other indications for sur-
gical excision were the uncertain diagnosis, the long latent inter-
val between diagnosis of the primary tumor and detection of the 
brain metastasis, the potential for the increasing mass to pro-
duce severe neurologic disability or death, the demonstrated 
fourth ventricle shift, and the low tumor burden elsewhere in the 
body suggesting the potential for protonged survival. Unfortu-
nately, the patient's general medical condition required a pro-
longed hospital stay although his neurologic status was stable 
postoperafively and did not contribute to his prolonged hospital 
course. Very likely, undetected pulmonary metastases worsened 
his already compromised pulmonary function and contributed 
to his death. 
Nevertheless, with cunent microsurgical and stereotactic ad-
vances, brainstem metastasis can be accessible and treated with 
surgical excision. 
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